 |
Articles: HIV/Immunodeficiency |
Prior Articles
Progress on the Induction of Neutralizing Antibodies Against HIV Type 1 (HIV-1)
BioDrugs, 08/06/09
Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index
HIV Medicine, 08/05/09 Pharmacokinetics of Concurrent Administration of Fosamprenavir and Atazanavir without Ritonavir in Human Immunodeficiency Virus–Negative Subjects
Pharmacotherapy, 08/05/09 Bridging the gap between adult and paediatric outcomes in HIV-1 vertically infected children: a single-centre comparison with adult data
Acta Pediatrica, 08/05/09 Determining seminal plasma HIV-1 load in the context of efficient HAART
Journal of Clinical Microbiology, 08/05/09 Identification of Performance Problems in a Commercial HIV-1 EIA by Multi-User External Quality Control Monitoring and Real-Time Data Analysis
Journal of Clinical Microbiology, 08/05/09 Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment
HIV Medicine, 08/05/09 High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy
HIV Medicine, 08/05/09 Predictors of Virologic Failure and Genotypic Resistance Mutation Patterns in Thai Children Receiving Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
The Pediatric Infectious Disease Journal, 08/05/09 Smoking cessation in HIV patients: rate of success and associated factors
HIV Medicine, 08/05/09
Exclusive Author Commentary Reduced frequency of CD4+CD25HIGHFOXP3+ cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: A link to autoimmunity
Clinical Immunology, 08/05/09 Risk Factors and Clinical Characteristics Associated with Hospitalization for Community-Acquired Bacterial Pneumonia in HIV-Positive Patients According to the Presence of Liver Cirrhosis
Infection, 08/05/09 Occurrence of Selective Ritonavir Nonadherence and Dose-Staggering in Recipients of Boosted HIV-1 Protease Inhibitor Therapy
HIV Clinical Trials, 08/05/09 Steady-State Amprenavir, Tenofovir, and Emtricitabine Pharmacokinetics Before and After Reducing Ritonavir Boosting of a Fosamprenavir/Tenofovir/Emtricitabine Regimen from 200 mg to 100 mg Once Daily
HIV Clinical Trials, 08/05/09 Detection of the protease codon 35 amino acid insertion in sequences from treatment-naïve HIV-1 subtype C infected individuals in the Central Region of Portugal
Journal of Clinical Virology, 08/05/09 Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity
Journal of Clinical Virology, 08/05/09 Utility of abdominal ultrasonography in HIV patients
Singapore Medical Journal, 08/05/09
Free full text
Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis
Journal of Infection, 08/04/09 Efficacy and Safety of Privigen in Children and Adolescents With Primary Immunodeficiency
Pediatric Asthma, Allergy & Immunology, 08/03/09 Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial : The Lancet
The Lancet - Early Online Publication, 08/03/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Allergy, Clinical Immunology, Annals of Allergy, Asthma, and Immunology
more...
|
250 Available Pages
|
|
